SCHEMBL8197285

SCHEMBL8197285

[C]#Cc1ccc2c(c1)C(SC)(SC)CCO2

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.33
AKR1B10 O60218 1/20 0.33
MAPT P10636 1/20 0.33
AKR1A1 P14550 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4372497 0.85 AKR1B1 (0.31) AKR1B1AKR1B10MAPTAKR1A1
SCHEMBL4373679 0.82 APP (0.30)
SCHEMBL8671663 0.80 RARA (0.45) AKR1B1AKR1B10MAPTAKR1A1
SCHEMBL4373634 0.77 LMNA (0.42) MAPT
SCHEMBL9054289 0.77 MAPT (0.41) AKR1B1MAPT
SCHEMBL9817651 0.77 RARB (0.53)
SCHEMBL7566669 0.76 RARA (0.35) AKR1B1MAPT
Hydrochloric Acid SCHEMBL21750681 0.76 MAPT (0.44) AKR1B1MAPT
SCHEMBL20636862 0.75 BACE1 (0.36)
SCHEMBL20636854 0.74 RARA (0.37) AKR1B1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003569-A2 STERILE BIOERODIBLE IMPLANT DEVICE WITH IMPROVED BIOCOMPATABILITY AND METHOD Allergan Sales, Inc. (US) 2000-05-31 EP disclosed
WO-1999007418-A2 STERILE BIOERODIBLE IMPLANT DEVICE WITH IMPROVED BIOCOMPATABILITY AND METHOD ALLERGAN SALES, INC. (US) 1999-02-18 WO disclosed